Neurology and Neuroradiology

Addressing the rising burden of neurodegenerative diseases like Alzheimer’s, Parkinson’s, and Huntington’s disease, this session will explore early diagnosis techniques, including biomarkers and genetic testing. It will also cover new therapeutic strategies such as gene therapy, monoclonal antibodies, and neuroprotective drugs aimed at slowing disease progression. The session will emphasize the importance of early detection, personalized medicine, and future treatment prospects in neurodegenerative disease management.

This session focuses on the pathophysiology, diagnosis, and treatment of stroke and other cerebrovascular disorders. Topics include advances in thrombolysis, endovascular treatment, neurorehabilitation, and prevention strategies. The session will also discuss emerging technologies like mobile stroke units, AI-driven diagnostics, and personalized treatment plans, along with post-stroke recovery interventions aimed at improving patient outcomes and quality of life.

This session will delve into the latest advancements in diagnosing and treating primary and metastatic brain tumors. It will cover surgical techniques, radiation therapy, immunotherapy, and targeted therapies. Attendees will learn about innovative treatments like stereotactic radiosurgery, tumor-treating fields, and the role of precision medicine in brain cancer management, improving patient survival rates and quality of life.

This session will review breakthroughs in understanding the mechanisms of epilepsy, along with advancements in treatment. Topics include neurostimulation devices like vagus nerve stimulation (VNS) and responsive neurostimulation (RNS), novel antiepileptic drugs, and surgery for drug-resistant epilepsy. Researchers will also explore the potential of gene therapy and diet-based therapies, such as the ketogenic diet, in managing seizures.

Focusing on recent advances in understanding multiple sclerosis (MS), this session will cover immune system dysregulation, the role of neuroinflammation, and the discovery of new biomarkers. Attendees will also explore disease-modifying therapies (DMTs), remyelination strategies, and personalized treatment plans for managing relapsing and progressive forms of MS, with a focus on improving patient outcomes.

This session explores the mechanisms underlying neuropathic pain and its management through pharmacological and non-pharmacological interventions. Topics include advancements in neurostimulation, targeted drug delivery, and novel therapies such as cannabinoids and neurotrophic factors. Attendees will learn how to tailor treatments to individual patients, improving pain management and quality of life.

This session will explore how advancements in neurogenetics are transforming the diagnosis and treatment of hereditary neurological disorders. Topics include genetic testing, CRISPR gene editing, and RNA-based therapies. Attendees will gain insight into personalized medicine approaches, targeting specific genetic mutations in diseases like ALS, Huntington’s disease, and spinal muscular atrophy, offering tailored treatment solutions.

This session will focus on the science of neuroplasticity and its therapeutic applications in brain repair. Topics include the role of stem cells, neurotrophic factors, and rehabilitative techniques to promote recovery after stroke, traumatic brain injury (TBI), and neurodegenerative diseases. Attendees will explore current research in enhancing neural regeneration and synaptic plasticity to restore lost functions.

This session will discuss the role of neuroinflammation in the pathogenesis of autoimmune neurological disorders such as multiple sclerosis, Guillain-Barré syndrome, and neuromyelitis optica. Attendees will explore current research on immune-modulating therapies, the role of cytokines and chemokines, and new treatment options aimed at reducing inflammation and neurodegeneration.

Focused on neurological disorders in children, this session will cover conditions such as epilepsy, autism spectrum disorders, and cerebral palsy. Attendees will learn about new diagnostic methods, including genetic testing and neuroimaging, and cutting-edge treatment approaches, including neurostimulation and early intervention strategies for improving long-term outcomes in pediatric patients.

This session will explore the latest advancements in neurocritical care, covering the management of acute neurological conditions such as traumatic brain injury, stroke, and status epilepticus. Attendees will learn about innovations in neuroprotection, intracranial pressure monitoring, and neurointensive care protocols, improving survival rates and long-term outcomes.

This session will review the use of functional neurosurgery, particularly deep brain stimulation (DBS), in treating movement disorders like Parkinson’s disease and dystonia. Attendees will explore new DBS applications for psychiatric conditions such as obsessive-compulsive disorder and depression, as well as advancements in neuromodulation technologies and personalized DBS programming.

Exploring the intersection of brain function and behavior, this session will focus on disorders such as ADHD, schizophrenia, and dementia. Topics include the neural circuits underlying cognition and behavior, and emerging therapies like cognitive-behavioral therapy, neurofeedback, and psychopharmacology aimed at improving patient outcomes.

This session will cover the latest developments in neuropharmacology, including new drugs for treating neurological disorders such as depression, epilepsy, and neurodegenerative diseases. Attendees will also learn about advancements in neuroprotective agents, neurotrophins, and regenerative therapies that promote neuronal repair.

This session will highlight the growing role of telemedicine in neurology, particularly in remote diagnosis and management of neurological conditions. Topics will include the benefits of telemedicine for stroke care, epilepsy monitoring, and movement disorder management, as well as the challenges of integrating telemedicine into clinical practice.

Focused on traumatic brain and spinal cord injuries, this session will discuss mechanisms of injury, advancements in neuroprotective therapies, and rehabilitation strategies. Attendees will learn about the latest research in neurodegeneration, neuroplasticity, and innovative rehabilitation methods aimed at maximizing recovery.

This session will explore the ethical dilemmas in neurology and neurosurgery, including issues related to brain-computer interfaces, informed consent in cognitively impaired patients, and the ethics of emerging neuroethologies. Attendees will discuss how to navigate these challenges while balancing patient care and scientific advancement.

This session will focus on the role of advanced imaging techniques in diagnosing and managing neurological diseases. Topics include the use of functional MRI, diffusion tensor imaging, and PET scans for detecting brain abnormalities, as well as emerging AI applications in neuroradiology to improve diagnostic accuracy and treatment planning.

This session will cover the latest advancements in neurorehabilitation, including robotic-assisted therapies, virtual reality, and brain-computer interfaces. Attendees will explore innovative approaches to improving motor and cognitive recovery in patients with stroke, spinal cord injuries, and neurodegenerative conditions, enhancing their quality of life.